Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: A prospective matched controlled study

Metabolism: Clinical and Experimental

Volumn 62, Issue 4, 2013, Pages 518-526

  Sharara, Ala I ^a   El Halabi, Mustapha M ^a   Ghaith, Ola A ^a   Habib, Robert H ^a   Mansour, Nabil M ^a   Malli, Ahmad ^a   El Hajj Fuleihan, Ghada ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Acid; Bone turnover; Calciotropic hormones; Fracture; Osteoporosis

Indexed keywords

ALBUMIN; CALCIUM; CALCIUM ION; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; CREATININE; ESOMEPRAZOLE; LANSOPRAZOLE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; RABEPRAZOLE; VITAMIN D;

ADULT; ARTICLE; BONE METABOLISM; CALCIUM INTAKE; CALCIUM METABOLISM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN DEFICIENCY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; COLLAGEN TYPE I; ENDPOINT DETERMINATION; HEARTBURN; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; YOUNG ADULT;

EID: 84884211484     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.09.011     Document Type: Article

References (45)

1. R.S. Sandler, J.E. Everhart, and M. Donowitz The burden of selected digestive diseases in the United States Gastroenterology 122 2002 1500 1511
2. R.T. Jensen Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas Basic Clin Pharmacol Toxicol 98 2006 4 19
3. H. Khalili, E.S. Huang, and B.C. Jacobson Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study BMJ 344 2012 e372
4. C.S. Kwok, J.K. Yeong, and Y.K. Loke Meta-analysis: risk of fractures with acid-suppressing medication Bone 48 2011 768 776
5. J.A. Kaye, and H. Jick Proton pump inhibitor use and risk of hip fractures in patients without major risk factors Pharmacotherapy 28 2008 951 959
6. E.W. Yu, T. Blackwell, and K.E. Ensrud Acid-suppressive medications and risk of bone loss and fracture in older adults Calcif Tissue Int 83 2008 251 259
7. U.S. Food and Drug Administration. FDA drug safety communication: possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors.
8. E.W. Yu, S.R. Bauer, and P.A. Bain Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies Am J Med 124 2011 519 526
9. S. Ngamruengphong, G.I. Leontiadis, and S. Radhi Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies Am J Gastroenterol 106 2011 1209 1218 [quiz 19]
10. R.R. Recker Calcium absorption and achlorhydria N Engl J Med 313 1985 70 73
11. A.R. Sheraly, D. Lickorish, and F. Sarraf Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo Curr Drug Deliv 6 2009 192 198
12. M.L. Gass, R. Kagan, and J.D. Kohles Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women Menopause 15 2008 667 675
13. M.M. Salamoun, A.S. Kizirian, and R.I. Tannous Low calcium and vitamin D intake in healthy children and adolescents and their correlates Eur J Clin Nutr 59 2005 177 184
14. M.J. Wright, R.R. Sullivan, and E. Gaffney-Stomberg Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial J Bone Miner Res 25 2010 2205 2211
15. L.E. Targownik, L.M. Lix, and C.J. Metge Use of proton pump inhibitors and risk of osteoporosis-related fractures CMAJ 179 2008 319 326
16. Y.X. Yang, J.D. Lewis, and S. Epstein Long-term proton pump inhibitor therapy and risk of hip fracture JAMA 296 2006 2947 2953
17. S.J. Lewis, S. Franco, and G. Young Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole Aliment Pharmacol Ther 10 1996 557 561
18. M. Epstein, S. McGrath, and F. Law Proton-pump inhibitors and hypomagnesemic hypoparathyroidism N Engl J Med 355 2006 1834 1836
19. M.A. Broeren, E.A. Geerdink, and H.L. Vader Hypomagnesemia induced by several proton-pump inhibitors Ann Intern Med 151 2009 755 756
20. M.A. Kenney, H. McCoy, and L. Williams Effects of magnesium deficiency on strength, mass, and composition of rat femur Calcif Tissue Int 54 1994 44 49
21. K. Mizunashi, Y. Furukawa, and K. Katano Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans Calcif Tissue Int 53 1993 21 25
22. C. Serfaty-Lacrosniere, R.J. Wood, and D. Voytko Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans J Am Coll Nutr 14 1995 364 368
23. G. Graziani, G. Como, and S. Badalamenti Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects Nephrol Dial Transplant 10 1995 1376 1380
24. G. Graziani, S. Badalamenti, and G. Como Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron 91 2002 474 479
25. M.B. O'Connell, D.M. Madden, and A.M. Murray Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial Am J Med 118 2005 778 781
26. P. Hardy, A. Sechet, and C. Hottelart Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis Artif Organs 22 1998 569 573
27. K.E. Hansen, A.N. Jones, and M.J. Lindstrom Do proton pump inhibitors decrease calcium absorption? J Bone Miner Res 25 2010 2510 2519
28. I. Kocsis, A. Arato, and H. Bodanszky Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children Calcif Tissue Int 71 2002 129 132
29. S.L. Gray, A.Z. LaCroix, and J. Larson Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative Arch Intern Med 170 2010 765 771
30. L.E. Targownik, L.M. Lix, and S. Leung Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss Gastroenterology 138 2010 896 904
31. J. Tuukkanen, and H.K. Vaananen Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro Calcif Tissue Int 38 1986 123 125
32. J.M. Moon, J.A. Park, and B.J. Lee The effect of PPI (proton pump inhibitors) on the bone mineral density, bone microstructure and bone metabolism of rat Gut 59 Suppl. III 2010 A110
33. R. Gagnemo-Persson, A. Samuelsson, and R. Hakanson Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol, and restricted food intake Calcif Tissue Int 61 1997 210 215
34. Y.X. Yang Proton pump inhibitor therapy and osteoporosis Curr Drug Saf 3 2008 204 209
35. R.J. Valuck, and J.M. Ruscin A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults J Clin Epidemiol 57 2004 422 428
36. R.K. Rude, F.R. Singer, and H.E. Gruber Skeletal and hormonal effects of magnesium deficiency J Am Coll Nutr 28 2009 131 141
37. B.C. Jacobson, T.G. Ferris, and T.L. Shea Who is using chronic acid suppression therapy and why? Am J Gastroenterol 98 2003 51 58
38. A. Arabi, R. El Rassi, and G. El-Hajj Fuleihan Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes Nat Rev Endocrinol 6 2010 550 561
39. A.G. Need, P.D. O'Loughlin, and H.A. Morris Vitamin D metabolites and calcium absorption in severe vitamin D deficiency J Bone Miner Res 23 2008 1859 1863
40. T.D. Thacher, and S.A. Abrams Relationship of calcium absorption with 25(OH)D and calcium intake in children with rickets Nutr Rev 68 2010 682 688
41. IoM Food and Nutrition Board (2011) Dietary reference intakes for calcium and vitamin D. pp. 263-7. The National Academies Press, Washington DC.
42. A. Arabi, Z. Mahfoud, L. Zahed, L. El-Onsi, and G. El-Hajj Fuleihan Effect of age, gender and calciotropic hormones on the relationship between vitamin D receptor gene polymorphisms and bone mineral density Eur J Clin Nutr 64 2010 383 391
43. A. Arabi, R. Baddoura, R. El-Rassi, and G. El-Hajj Fuleihan Age but not gender modulates the relationship between PTH and vitamin D Bone 47 2010 408 412
44. S. Vasikaran, R. Eastell, and O. Bruyere Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards Osteoporos Int 22 2011 391 420
45. P. Moayyedi, and A. Cranney Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm Am J Gastroenterol 103 2008 2428 2431